SS Innovations International (SSII) Cash & Equivalents (2016 - 2026)
SS Innovations International (SSII) posted Cash & Equivalents of $16.0 million for Q1 2026, up 398.37% sequentially from $3.2 million in Q4 2025, and up 0.67% YoY from $15.9 million in Q1 2025.
SS Innovations International (SSII) Cash & Equivalents (2016 - 2026) Analysis & Trends
SS Innovations International has reported Cash & Equivalents for 11 years, with the latest figure at $16.0 million in Q1 2026.
- Quarterly Cash & Equivalents rose 0.67% year-over-year to $16.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.0 million (up 0.67% YoY) and the FY2025 annual result came in at $3.2 million, up 587.33% from the prior year.
- Cash & Equivalents rose to $16.0 million in Q1 2026 per SSII's latest filing, from $3.2 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $16.0 million in Q1 2026 and troughed at $217177.0 in Q4 2022.
- A 5-year average of $3.8 million and a median of $608215.0 in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents plunged 96.66% in 2024, then jumped 2478.39% in 2025.
- Over 5 years, Cash & Equivalents stood at $217177.0 in 2022, then jumped by 831.16% to $2.0 million in 2023, then sank by 76.93% to $466500.0 in 2024, then jumped by 587.33% to $3.2 million in 2025, then surged by 398.37% to $16.0 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $16.0 million, $3.2 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | SS Innovations International | 731.50 Mn | 709.20 Mn | 7.10 Mn | 13.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.65 Mn |
| Mar 31, 2026 | 15.98 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 11.38 Mn |
| Mar 31, 2025 | 15.87 Mn |
| Dec 31, 2024 | 466,500.00 |
| Sep 30, 2024 | 220,357.00 |
| Jun 30, 2024 | 608,215.00 |
| Mar 31, 2024 | 948,119.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 423,062.00 |
| Mar 31, 2023 | 448,543.00 |
| Dec 31, 2022 | 217,177.00 |
| Sep 30, 2022 | 514,143.00 |
| Jun 30, 2022 | 261,089.00 |
| Mar 31, 2022 | 346,869.00 |
| Dec 31, 2021 | 405,774.00 |
| Sep 30, 2021 | 205,195.00 |